Comparing the Immune Response to PEEK as an Implant Material with and without P-15 Peptide as Bone Graft Material in a Rabbit Long Bone Model
Authors:
- Boyle C. ChengBCBoyle C. Cheng
- Isaac R. SwinkISIsaac R. Swink
- Cooper T. ChengCCCooper T. Cheng
- Owen G. CorcoranOCOwen G. Corcoran
- Vicki Z. WangVWVicki Z. Wang
- Edward J. McClainEMEdward J. McClain
- Praveer S. VyasPVPraveer S. Vyas
- Izzy OwenIOIzzy Owen
- Chen XuCXChen Xu
- Daniel T. AltmanDADaniel T. Altman
- Alexander K. YuAYAlexander K. Yu
Open Access
- 6 September 2024
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 11 (9) , 898
Abstract
P-15 is a 15-amino-acid-long biomimetic peptide widely demonstrated to enhance osteogenesis in vivo. Despite the prevalence of polyether-ether-ketone (PEEK) in interbody device manufacturing, a growing body of evidence suggests it may produce an unfavorable immune response. The purpose of this preliminary study was to characterize the immune response and new bone growth surrounding PEEK implants with and without a P-15 peptide-based osteobiologic. A bilateral femoral defect model was conducted using New Zealand white rabbits. A total of 17 test subjects received one implant in each distal femur, either with or without bone graft material. Animals were allowed to survive to 4 or 8 weeks, at which time the femurs were collected and subjected to micro-computer tomography (microCT) or cytokine analysis. MicroCT analysis included the quantification of bone growth and density surrounding each implant. The cytokine analysis of periprosthetic tissue homogenates included the quantification of interleukins (ILs) and TNF-α expression via ELISA kits. Improvements in bone volume were observed in the P-15 cohort for the regions of interest, 500–136 and 136–0 µm from the implant surface, at 8 weeks post-op. Concentrations of IL-1β, IL-4, and IL-6 cytokines were significantly higher in the P-15 cohort compared to the PEEK cohort at the 4-week timepoint. Significant reductions in the concentrations of IL-4 and IL-6 cytokines from the 4- to 8-week cohort were observed in the P-15 cohort only. The P-15 peptide has the potential to modulate the immune response to implanted materials. We observed improvements in bone growth and a more active micro-environment in the P-15 cohort relative to the PEEK control. This may indicate an earlier transition from the inflammatory to remodeling phase of healing.Keywords
Funding Information
- Cerapedics, Inc.
This publication has 31 references indexed in Scilit:
- Classical and Paradoxical Effects of TNF-α on Bone HomeostasisFrontiers in Immunology, 2014
- BMP-2 Adverse Reactions Treated With Human Dose Equivalent Dexamethasone in a Rodent Model of Soft-Tissue InflammationSpine, 2013
- Anterior cervical discectomy and fusion: Comparison of titanium and polyetheretherketone cagesBMC Musculoskeletal Disorders, 2012
- The biology of fracture healingInjury, 2011
- High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In VivoTissue Engineering Part A, 2011
- Osteoimmunology: cytokines and the skeletal systemBMB Reports, 2008
- Modulation of the Inflammatory Response for Enhanced Bone Tissue RegenerationTissue Engineering Part B: Reviews, 2008
- Proinflammatory cytokine (TNFα/IL‐1α) induction of human osteoclast formationThe Journal of Pathology, 2002
- Thickness of fibrous capsule after implantation of hydroxyapatite in subcutaneous tissue in ratsJournal of Biomedical Materials Research, 1999
- The Role in Cell Binding of a β1-bend within the Triple Helical Region in Collagen αl(I) Chain: Structural and Biological Evidence for Conformational Tautomerism on Fiber SurfaceJournal of Biomolecular Structure and Dynamics, 1997